Literature DB >> 3565511

Patterns of early visual field loss in open-angle glaucoma.

J Caprioli, M Sears, J M Miller.   

Abstract

We examined two groups of patients with primary open-angle glaucoma with distinctly different patterns of early visual field loss using two visual field indices: mean defect and loss variance. Patients were selected on the basis of visual field criteria only. Eight patients were selected for diffuse depression of the differential light sensitivity without localized scotomas (mean defect greater than 3.0 decibels, loss variance less than 10.0 decibels). Seven patients were selected for localized scotomas without diffuse depression of the differential light sensitivity (mean defect less than or equal to 3.0 decibels, loss variance greater than or equal to 20.0 decibels). Patients with diffuse depression manifested intraocular pressures that were higher (mean peak pressure +/- S.E.M., 27.6 +/- 1.2 mm Hg) than those with localized defects (22.4 +/- 1.4 mm Hg). The optic disk rim area of the localized loss group (mean +/- S.E.M., 1.02 +/- 0.15 mm2) was significantly smaller (P less than .05) than the disk rim area of the diffuse loss group (1.33 +/- 0.07 mm2). This difference was largely because of thinner temporal disk rims in the localized loss group. Different patterns of visual field loss may be caused by different mechanisms of glaucomatous optic nerve damage.

Entities:  

Mesh:

Year:  1987        PMID: 3565511     DOI: 10.1016/s0002-9394(14)74273-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

Review 1.  A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma.

Authors:  N N Osborne; J Melena; G Chidlow; J P Wood
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

2.  Optic nerve head characteristics in eyes with papillomacular bundle defects in glaucoma.

Authors:  Aparna Rao; Sujoy Mukherjee; Debananda Padhy
Journal:  Int Ophthalmol       Date:  2015-02-27       Impact factor: 2.031

3.  Pupillary evaluation of retinal asymmetry: development and initial testing of a technique.

Authors:  Yanjun Chen; Harry J Wyatt; William H Swanson
Journal:  Vision Res       Date:  2005-09       Impact factor: 1.886

4.  Light-sense, flicker and resolution perimetry in glaucoma: a comparative study.

Authors:  B J Lachenmayr; S M Drance; G R Douglas; F S Mikelberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

5.  Early glaucoma involves both deep local, and shallow widespread, retinal nerve fiber damage of the macular region.

Authors:  Donald C Hood; Anastasia Slobodnick; Ali S Raza; Carlos Gustavo de Moraes; Christopher C Teng; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-03       Impact factor: 4.799

6.  Problems related to diffuse versus localized loss in the perimetry of glaucomatous visual fields.

Authors:  A T Funkhouser; F Fankhauser; R A Weale
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  RA/DA cumulative curve analysis of local and diffuse neuroretinal rim area damage in glaucoma patients.

Authors:  M Rolando; A Macrì; M Iester; M Altieri; G Calabria
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

8.  Intraocular pressure and central visual field of normal tension glaucoma.

Authors:  M Araie; M Kitazawa; N Koseki
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

9.  Course of the optic nerve fibers through the lamina cibrosa in human eyes.

Authors:  A Dichtl; J B Jonas; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-09       Impact factor: 3.117

10.  Comparison of visual field defects between normal-tension and primary open-angle glaucoma in the late stage of the disease.

Authors:  M Araie; J Hori; N Koseki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.